Australia markets closed

Pliant Therapeutics, Inc. (PLRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.75+0.09 (+0.84%)
At close: 04:00PM EDT
10.75 0.00 (0.00%)
After hours: 04:20PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-170,743
-161,336
-123,321
-97,263
-41,533
-
Depreciation & amortisation
1,902
1,841
1,823
1,535
1,310
-
Stock-based compensation
42,226
44,483
22,598
10,437
3,895
-
Change in working capital
9,112
1,251
4,217
6,917
-1,209
-
Accounts receivable
3,297
1,983
15
7,281
-2,227
-
Accounts payable
5,370
2,969
-1,351
891
922
-
Other working capital
-118,606
-117,282
-96,391
-77,396
-38,803
-
Other non-cash items
2,462
2,390
1,858
1,669
266
-
Net cash provided by operating activities
-116,356
-116,361
-94,631
-75,443
-37,271
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,250
-921
-1,760
-1,953
-1,532
-
Purchases of investments
-358,824
-583,069
-325,716
-219,887
-322,605
-
Sales/maturities of investments
467,816
456,978
177,272
295,539
113,271
-
Other investing activities
-
-
-
-
-
-254
Net cash used for investing activities
106,742
-127,012
-150,204
73,699
-210,866
-
Cash flows from financing activities
Common stock issued
5,001
275,252
217,561
2,984
161,193
-
Other financing activities
-
-847
-707
-457
-
-2,582
Net cash used provided by (used for) financing activities
22,867
274,405
226,854
2,527
213,212
-
Net change in cash
13,253
31,032
-17,981
783
-34,925
-
Cash at beginning of period
102,527
33,684
51,665
50,882
85,807
-
Cash at end of period
115,780
64,716
33,684
51,665
50,882
-
Free cash flow
Operating cash flow
-116,356
-116,361
-94,631
-75,443
-37,271
-
Capital expenditure
-2,250
-921
-1,760
-1,953
-1,532
-
Free cash flow
-118,606
-117,282
-96,391
-77,396
-38,803
-